ProfileGDS4718 / 215063_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 87% 83% 86% 87% 82% 83% 85% 86% 85% 83% 88% 84% 82% 83% 83% 82% 85% 82% 94% 84% 84% 83% 84% 87% 78% 85% 86% 88% 86% 83% 83% 88% 83% 84% 80% 85% 85% 86% 79% 84% 88% 84% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8963488
GSM549102patient 115, normal, homogenized [OPG study]8.6989587
GSM549104patient 119, normal, homogenized [OPG study]8.276883
GSM549108patient 138, normal, homogenized [OPG study]8.5701286
GSM549119patient 077, normal, homogenized [OPG study]8.7672487
GSM549133patient 032, cancer, homogenized [OPG study]8.1974682
GSM549139patient 042, cancer, homogenized [OPG study]8.2806783
GSM549099patient 107, normal, homogenized [OPG study]8.3322385
GSM549109patient 139, normal, homogenized [OPG study]8.6181286
GSM549110patient 046, normal, homogenized [OPG study]8.4088485
GSM549114patient 063, normal, homogenized [OPG study]8.3194183
GSM549122patient 082, normal, homogenized [OPG study]8.8204688
GSM549134patient 033, cancer, homogenized [OPG study]8.3187284
GSM549136patient 036, cancer, homogenized [OPG study]8.1745182
GSM549140patient 044, cancer, homogenized [OPG study]8.306183
GSM549111patient 047, normal, homogenized [OPG study]8.3053883
GSM549113patient 057, normal, homogenized [OPG study]8.2305582
GSM549132patient 031, cancer, homogenized [OPG study]8.4313485
GSM549137patient 038, cancer, homogenized [OPG study]8.1111382
GSM549142patient 047, cancer, homogenized [OPG study]9.450294
GSM549100patient 110, normal, homogenized [OPG study]8.269884
GSM549107patient 135, normal, homogenized [OPG study]8.3475684
GSM549115patient 068, normal, homogenized [OPG study]8.3323483
GSM549116patient 072, normal, homogenized [OPG study]8.4511584
GSM549120patient 078, normal, homogenized [OPG study]8.7091887
GSM549131patient 030, cancer, homogenized [OPG study]7.7696478
GSM549118patient 074, normal, homogenized [OPG study]8.504585
GSM549129patient 027, cancer, homogenized [OPG study]8.5274286
GSM549123patient 088, normal, homogenized [OPG study]8.8328988
GSM549124patient 006, cancer, homogenized [OPG study]8.4145486
GSM549126patient 015, cancer, homogenized [OPG study]8.2153483
GSM549128patient 025, cancer, homogenized [OPG study]8.2745983
GSM549103patient 117, normal, homogenized [OPG study]8.7828888
GSM549117patient 073, normal, homogenized [OPG study]8.3538683
GSM549138patient 041, cancer, homogenized [OPG study]8.4145384
GSM549141patient 045, cancer, homogenized [OPG study]8.0299680
GSM549130patient 028, cancer, homogenized [OPG study]8.3859285
GSM549101patient 111, normal, homogenized [OPG study]8.4752885
GSM549105patient 128, normal, homogenized [OPG study]8.4986186
GSM549106patient 134, normal, homogenized [OPG study]7.9244779
GSM549112patient 048, normal, homogenized [OPG study]8.4028784
GSM549125patient 011, cancer, homogenized [OPG study]8.7557388
GSM549127patient 024, cancer, homogenized [OPG study]8.3754484
GSM549135patient 035, cancer, homogenized [OPG study]8.0987481